Beat the Nasdaq With This Cash-Gushing Dividend Stock
Shares of Amgen have rallied at the start of 2025 despite the broader stock market sell-off. Amgen benefits from its portfolio of best-in-class therapeutics, alongside an extensive pipeline. The stock's 3.3% dividend yield looks compelling, backed by …